These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8757968)

  • 1. A sequence analysis of von Willebrand factor mRNA, gene, and pseudogene in two patients with von Willebrand disease type 2B, and an investigation of gene conversion in its gene.
    Kanaji T; Okamura T; Kuroiwa M; Murakawa M; Kamura T; Niho Y
    Int J Hematol; 1996 Jul; 64(1):53-9. PubMed ID: 8757968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.
    Randi AM; Rabinowitz I; Mancuso DJ; Mannucci PM; Sadler JE
    J Clin Invest; 1991 Apr; 87(4):1220-6. PubMed ID: 2010538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.
    Eikenboom JC; Vink T; Briët E; Sixma JJ; Reitsma PH
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2221-4. PubMed ID: 8134377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common VWF exon 28 haplotype in the Turkish population.
    Berber E; Pehlevan F; Akin M; Capan OY; Kavakli K; Çaglayan SH
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):550-6. PubMed ID: 22473027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease.
    Sugiura I; Matsushita T; Tanimoto M; Takahashi I; Yamazaki T; Yamamoto K; Takamatsu J; Kamiya T; Saito H
    Thromb Haemost; 1992 Jun; 67(6):612-7. PubMed ID: 1380739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
    Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
    Lavergne JM; De Paillette L; Bahnak BR; Ribba AS; Fressinaud E; Meyer D; Pietu G
    Br J Haematol; 1992 Sep; 82(1):66-72. PubMed ID: 1419804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
    Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
    Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A database of polymorphisms in the von Willebrand factor gene and pseudogene. For the Consortium on von Willebrand Factor Mutations and Polymorphisms and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    Sadler JE; Ginsburg D
    Thromb Haemost; 1993 Feb; 69(2):185-91. PubMed ID: 8456432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
    Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
    Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease.
    Bernardi F; Patracchini P; Gemmati D; Pinotti M; Schwienbacher C; Ballerini G; Marchetti G
    Hum Mol Genet; 1993 May; 2(5):545-8. PubMed ID: 8518792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
    Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
    Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A de novo mutation in exon 28 of the von Willebrand factor gene in a patient with type IIA von Willebrand's disease coincides with an MboI polymorphism in the von Willebrand factor pseudogene.
    Pérez-Casal M; Daly M; Peake I
    Hum Mol Genet; 1993 Dec; 2(12):2159-61. PubMed ID: 7906590
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.
    Siguret V; Lavergne JM; Chérel G; Boyer-Neumann C; Ribba AS; Bahnak BR; Meyer D; Piétu G
    Hum Genet; 1994 Feb; 93(2):95-102. PubMed ID: 7906671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The von Willebrand factor gene and genetics of von Willebrand's disease.
    Ginsburg D
    Mayo Clin Proc; 1991 May; 66(5):506-15. PubMed ID: 2030619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
    Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
    Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HphI-polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand's disease.
    Donnér M; Holmberg L; Kristoffersson AC; Nilsson IM
    Br J Haematol; 1991 Jul; 78(3):403-7. PubMed ID: 1873222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies.
    Castaman G; Platè M; Giacomelli SH; Rodeghiero F; Duga S
    J Thromb Haemost; 2010 Dec; 8(12):2736-42. PubMed ID: 20854374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.